Nicole Long28 said:Surgery isn't even an option here, especially since there's an oral version available—and for quite some time now http://annonc.oxfordjournals.org/con.../11/1643.short , http://www.ncbi.nlm.nih.gov/pubmed/11822766 , http://www.wales.nhs.uk/sites3/Docum...ne%20final.pdf . I can't decide if the doctor simply doesn't know this, or if he knows and just didn't offer his patient an alternative—or at least didn't explain how to actually get the medication. It’s likely the hospital could order it under their own name if they paid for it. There is a massive difference between taking a pill and being cut open.
Those links point to study results. Just because a study exists doesn't mean the drug is actually in clinical use. The road from research results to official approval for clinical use is long, winding, and full of obstacles. It looks like it was approved in England back in 2007, but it's unclear why it wasn't cleared for the rest of Europe. Clearly, something went sideways at the finish line, possibly related to the extreme neutropenia seen during application, according to the British reports. They further state:
In the studies submitted oral vinorelbine was mostly used as a first line therapy in advanced disease and the majority of patients had not received prior
anthracycline based chemotherapy. This does not fit with the current NICE guidance
where vinorelbine (IV) monotherapy is recommended as one option for second line or
later therapy for the treatment of advanced breast cancer when anthracycline based
regimens have failed or are unsuitable. Basically, the drug was given in these studies to patients in the first line of therapy for advanced disease
who hadn't undergone any other form of chemotherapy yet . That completely contradicts the NICE (American Medicare-style) guidelines, which recommend vinorelbine via IV as a second-line treatment after the first line fails or relapses. Based on this, we have no idea how the drug would perform in a second-line setting because the study doesn't cover it. Furthermore, they highlight what I consider the most critical point:
Presently, the use of oral vinorelbine is limited by the lack of randomised, controlled trials and comparative data. Nevertheless, in view of its relatively milder toxicity
profile, elderly and/or frail patients or those prioritising other aspects of quality of life may choose vinorelbine over more established cytotoxic agents. Further welldesigned prospective studies are needed in order to provide more information on
safety, tolerability and the optimal dose especially in patients with pre-treated metastatic breast cancer. They should include randomised studies comparing intravenous with oral vinorelbine to confirm equivalent efficacy and safety profiles.
Further Studies investigating The value of Oral vinorelbine in combination therapy in general ara also required , along with comparative clinical trials to Help clarify The Place of Oral vinorelbine in The Management of Advanced breast cancer. In short, a mountain of research is still needed to prove it works as well as the IV version. If you ask me, the study was poorly executed. They poured a fortune into a potentially great drug but failed to do the necessary legwork immediately.
The doctor definitely knows all of this, but beyond his medical knowledge, he also understands how the bureaucratic machine grinds. Suggesting a therapy that isn't officially accessible is highly unprofessional; in that sense, a physician is neither allowed nor able to propose it. If a study is still active somewhere, you might try submitting a request to be included, provided you meet the eligibility criteria.
There’s simply no other way to get this done right now.
As for the port, honestly, I think you're just making a scene because you don't quite grasp how it works. It isn't some massive surgical incision; it's just a tiny little access point in a vein in the chest where they slide in a small tube—a catheter—to deliver the treatment. Doctors do this every single day, even for little kids, and it's really not the monster people make it out to be. If anything, it makes getting your meds a hell of a lot easier.
Edit:
Here's a visual for you: http://www.youtube.com/watch?v=6wCn4nEYLqw